US 8168588
Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditions
granted A61KA61K38/1808A61K38/1825
Quick answer
US patent 8168588 (Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditions) held by Five Prime Therapeutics, Inc. expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/1808, A61K38/1825, A61K38/1858, A61K38/1866